Table 2 Network meta-analysis results of efficacy outcomes
From: Comparative efficacy of treatments for patients with knee osteoarthritis: a network meta-analysis
Pain | |||||
 HA | − 0.47 (− 1.6, 0.67) | 0.46 (− 0.32, 1.25) | − 0.56 (− 1.18, 0.07) | 0.88 (− 0.17, 1.86) | Stiffness |
 1.4 (− 0.95, 3.65) | Corticosteroid | 0.93 (− 0.35, 2.22) | − 0.09 (− 1.19, 1.02) | 1.35 (− 0.16, 2.78) | |
 − 1.41 (-2.9, 0.03) | − 2.82 (− 5.35, − 0.22) | PRP | − 1.02 (− 1.76, − 0.28) | 0.41 (− 0.64, 1.39) | |
 1.66 (0.39, 2.89) | 0.25 (− 1.99, 2.56) | 3.07 (1.62, 4.53) | Placebo | 1.44 (0.3, 2.49) | |
 − 1.4 (-3.56, 0.84) | − 2.81 (− 5.82, 0.4) | 0 (− 2.11, 2.25) | − 3.06 (− 5.36, − 0.63) | HA + PRP | |
Physical function | |||||
 HA | − 4.25 (− 12.88, 4.66) | 8.37 (0.55, 16.49) | − 6.17 (− 12.15, − 0.02) | 13.32 (2.86, 23.91) | Total |
 2.62 (− 6.64, 11.74) | Corticosteroid | 12.62 (1.48, 23.72) | − 1.94 (− 11.39, 7.41) | 17.56 (4.07, 30.85) | |
 − 6.3 (− 12.98, 0.26) | − 8.92 (-19.39, 1.74) | PRP | − 14.56 (− 22.02, − 7.19) | 4.94 (− 5.43, 15.2) | |
 4.14 (− 1.19, 9.21) | 1.51 (-7.66, 10.7) | 10.43 (4.21, 16.58) | Placebo | 19.5 (8.4, 30.51) | |
 − 11.15 (− 19.83, − 2.62) | − 13.78 (− 26.09, − 1.39) | − 4.85 (− 13.35, 3.65) | − 15.3 (− 24.42, − 6.06) | HA + PRP | |